share_log

千金药业(600479.SH)战略规划:力争2031年末营业收入达到80亿元

Qianjin Pharmaceutical (600479.SH) Strategic Plan: Strive to reach 8 billion yuan in revenue by the end of 2031

Gelonghui Finance ·  May 20 05:40

Gelonghui May 20 丨 Qianjin Pharmaceutical (600479.SH) announced the strategic plan outline (2024-2031), aiming to reach 8 billion yuan in revenue by the end of 2031, of which the pharmaceutical industry's revenue reached 5 billion yuan, and the net profit margin was not lower than the average of the pharmaceutical industry. From a leading pharmaceutical enterprise in Hunan Province to the top 100 pharmaceutical industry in the country, it has become the most influential benchmark enterprise in the field of women's health in China.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment